Clinically 0 10 0 10 O
significant 11 22 11 22 O
underlying 23 33 23 33 O
pulmonary 34 43 34 43 B-chronic_disease
disease 44 51 44 51 I-chronic_disease
as 52 54 52 54 O
measured 55 63 55 63 O
by 64 66 64 66 O
pulmonary 67 76 67 76 B-treatment
function 77 85 77 85 I-treatment
tests 86 91 86 91 I-treatment

Eastern 0 7 92 99 B-clinical_variable
Cooperative 8 19 100 111 I-clinical_variable
Oncology 20 28 112 120 I-clinical_variable
Group 29 34 121 126 I-clinical_variable
( 35 36 127 128 I-clinical_variable
ECOG 36 40 128 132 I-clinical_variable
) 40 41 132 133 I-clinical_variable
performance 42 53 134 145 I-clinical_variable
status 54 60 146 152 I-clinical_variable
of 61 63 153 155 O
0 64 65 156 157 B-lower_bound
- 65 66 157 158 O
1 66 67 158 159 B-upper_bound

Evidence 0 8 160 168 O
of 9 11 169 171 O
ischemia 12 20 172 180 B-chronic_disease
on 21 23 181 183 O
exercise 24 32 184 192 B-treatment
tolerance 33 42 193 202 I-treatment
test 43 47 203 207 O
, 47 48 207 208 O
stress 49 55 209 215 B-treatment
thallium 56 64 216 224 I-treatment
study 65 70 225 230 I-treatment
, 70 71 230 231 O
or 72 74 232 234 O
baseline 75 83 235 243 B-treatment
EKG 84 87 244 247 I-treatment

Histological 0 12 248 260 O
confirmation 13 25 261 273 O
of 26 28 274 276 O
predominant 29 40 277 288 O
conventional 41 53 289 301 O
( 54 55 302 303 B-cancer
clear 55 60 303 308 I-cancer
cell 61 65 309 313 I-cancer
) 65 66 313 314 I-cancer
renal 67 72 315 320 I-cancer
cancer 73 79 321 327 I-cancer

In 0 2 328 330 O
addition 3 11 331 339 O
, 11 12 339 340 O
women 13 18 341 346 B-gender
of 19 21 347 349 O
childbearing 22 34 350 362 O
potential 35 44 363 372 O
as 45 47 373 375 O
well 48 52 376 380 O
as 53 55 381 383 O
male 56 60 384 388 B-chronic_disease
patients 61 69 389 397 I-chronic_disease
must 70 74 398 402 O
agree 75 80 403 408 O
to 81 83 409 411 O
take 84 88 412 416 O
appropriate 89 100 417 428 O
precautions 101 112 429 440 O
to 113 115 441 443 O
avoid 116 121 444 449 O
pregnancy 122 131 450 459 B-pregnancy

Need 0 4 460 464 O
for 5 8 465 468 O
chronic 9 16 469 476 B-treatment
steroids 17 25 477 485 I-treatment

No 0 2 486 488 O
metastatic 3 13 489 499 O
site 14 18 500 504 O
amenable 19 27 505 513 O
to 28 30 514 516 O
SBRT 31 35 517 521 B-treatment

Patients 0 8 522 530 O
may 9 12 531 534 O
have 13 17 535 539 O
other 18 23 540 545 O
metastases 24 34 546 556 B-cancer
but 35 38 557 560 O
only 39 43 561 565 O
a 44 45 566 567 O
maximum 46 53 568 575 O
of 54 56 576 578 O
3 57 58 579 580 B-upper_bound
will 59 63 581 585 O
be 64 66 586 588 O
treated 67 74 589 596 O

Patients 0 8 597 605 O
must 9 13 606 610 O
be 14 16 611 613 O
â‰¥ 17 18 614 615 O
18 19 21 616 618 B-lower_bound
years 22 27 619 624 I-lower_bound
of 28 30 625 627 O
age 31 34 628 631 B-age

Patients 0 8 632 640 O
with 9 13 641 645 O
active 14 20 646 652 B-chronic_disease
systemic 21 29 653 661 I-chronic_disease
, 29 30 661 662 I-chronic_disease
pulmonary 31 40 663 672 I-chronic_disease
, 40 41 672 673 I-chronic_disease
or 42 44 674 676 I-chronic_disease
pericardial 45 56 677 688 I-chronic_disease
infection 57 66 689 698 I-chronic_disease

Patients 0 8 699 707 O
with 9 13 708 712 O
brain 14 19 713 718 B-cancer
metastases 20 30 719 729 I-cancer
not 31 34 730 733 O
candidates 35 45 734 744 O
for 46 49 745 748 O
radiosurgery 50 62 749 761 B-treatment
alone 63 68 762 767 O

Pregnant 0 8 768 776 B-pregnancy
or 9 11 777 779 O
lactating 12 21 780 789 O
women 22 27 790 795 B-gender
, 27 28 795 796 O
as 29 31 797 799 O
treatment 32 41 800 809 O
involves 42 50 810 818 O
unforeseeable 51 64 819 832 O
risks 65 70 833 838 O
to 71 73 839 841 O
the 74 77 842 845 O
embryo 78 84 846 852 O
or 85 87 853 855 O
fetus 88 93 856 861 O

Previous 0 8 862 870 O
radiation 9 18 871 880 B-treatment
to 19 21 881 883 O
sites 22 27 884 889 O
proposed 28 36 890 898 O
for 37 40 899 902 O
SBRT 41 45 903 907 O

Tumors 0 6 908 914 B-cancer
amenable 7 15 915 923 O
to 16 18 924 926 O
SBRT 19 23 927 931 B-treatment
in 24 26 932 934 I-treatment
lungs 27 32 935 940 I-treatment
( 33 34 941 942 O
central 34 41 942 949 O
locations 42 51 950 959 O
preferred 52 61 960 969 O
) 61 62 969 970 O
, 62 63 970 971 O
mediastinum 64 75 972 983 O
, 75 76 983 984 O
chest 77 82 985 990 O
wall 83 87 991 995 O
, 87 88 995 996 O
bones 89 94 997 1002 O
with 95 99 1003 1007 O
a 100 101 1008 1009 O
soft 102 106 1010 1014 O
tissue 107 113 1015 1021 O
component 114 123 1022 1031 O
( 124 125 1032 1033 O
other 125 130 1033 1038 O
than 131 135 1039 1043 O
long 136 140 1044 1048 O
bones 141 146 1049 1054 O
) 146 147 1054 1055 O
, 147 148 1055 1056 O
or 149 151 1057 1059 O
liver 152 157 1060 1065 O
, 157 158 1065 1066 O
liver 159 164 1067 1072 O
hilum 165 170 1073 1078 O
and 171 174 1079 1082 O
associated 175 185 1083 1093 O
lymph 186 191 1094 1099 O
nodes 192 197 1100 1105 O
( 198 199 1106 1107 O
inclusive 199 208 1107 1116 O
of 209 211 1117 1119 O
immediately 212 223 1120 1131 O
adjacent 224 232 1132 1140 O
masses 233 239 1141 1147 O
) 239 240 1147 1148 O
, 240 241 1148 1149 O
1 242 243 1150 1151 B-lower_bound
- 244 245 1152 1153 O
3 246 247 1154 1155 B-upper_bound
foci 248 252 1156 1160 B-clinical_variable
; 252 253 1160 1161 O
no 254 256 1162 1164 O
minimum 257 264 1165 1172 O
size 265 269 1173 1177 O
, 269 270 1177 1178 O
but 271 274 1179 1182 O
none 275 279 1183 1187 O
greater 280 287 1188 1195 O
than 288 292 1196 1200 O
7 293 294 1201 1202 B-upper_bound
cm 295 297 1203 1205 I-upper_bound

Women 0 5 1206 1211 B-gender
of 6 8 1212 1214 O
childbearing 9 21 1215 1227 O
potential 22 31 1228 1237 O
must 32 36 1238 1242 O
have 37 41 1243 1247 O
a 42 43 1248 1249 O
negative 44 52 1250 1258 O
serum 53 58 1259 1264 O
or 59 61 1265 1267 O
urine 62 67 1268 1273 B-pregnancy
pregnancy 68 77 1274 1283 I-pregnancy
test 78 82 1284 1288 O
within 83 89 1289 1295 O
72 90 92 1296 1298 B-upper_bound
hours 93 98 1299 1304 I-upper_bound
prior 99 104 1305 1310 I-upper_bound
to 105 107 1311 1313 O
the 108 111 1314 1317 O
start 112 117 1318 1323 O
of 118 120 1324 1326 O
protocol 121 129 1327 1335 O
treatment 130 139 1336 1345 O

